Rank | Gene Set | Z-score |
---|---|---|
1 | high-density lipoprotein particle remodeling (GO:0034375) | 5.83986918 |
2 | thymic T cell selection (GO:0045061) | 5.68751351 |
3 | establishment of skin barrier (GO:0061436) | 5.59584539 |
4 | regulation of water loss via skin (GO:0033561) | 5.58923469 |
5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.54571719 |
6 | positive regulation of natural killer cell differentiation (GO:0032825) | 5.53497124 |
7 | negative thymic T cell selection (GO:0045060) | 5.41602668 |
8 | reverse cholesterol transport (GO:0043691) | 5.41503481 |
9 | negative T cell selection (GO:0043383) | 5.37162631 |
10 | low-density lipoprotein particle remodeling (GO:0034374) | 5.31626074 |
11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.29690569 |
12 | ethanol oxidation (GO:0006069) | 5.17184491 |
13 | ER overload response (GO:0006983) | 5.15657712 |
14 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.15193806 |
15 | regulation of cholesterol esterification (GO:0010872) | 5.12057880 |
16 | tryptophan catabolic process (GO:0006569) | 4.98887088 |
17 | indole-containing compound catabolic process (GO:0042436) | 4.98887088 |
18 | indolalkylamine catabolic process (GO:0046218) | 4.98887088 |
19 | phospholipid homeostasis (GO:0055091) | 4.97008458 |
20 | carnitine metabolic process (GO:0009437) | 4.91196759 |
21 | amino-acid betaine metabolic process (GO:0006577) | 4.71255984 |
22 | phospholipid efflux (GO:0033700) | 4.61016699 |
23 | positive thymic T cell selection (GO:0045059) | 4.60157816 |
24 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.57044496 |
25 | kynurenine metabolic process (GO:0070189) | 4.56809680 |
26 | blood vessel maturation (GO:0001955) | 4.55717700 |
27 | aromatic amino acid family catabolic process (GO:0009074) | 4.55185531 |
28 | protein-lipid complex remodeling (GO:0034368) | 4.54146677 |
29 | macromolecular complex remodeling (GO:0034367) | 4.54146677 |
30 | plasma lipoprotein particle remodeling (GO:0034369) | 4.54146677 |
31 | tryptophan metabolic process (GO:0006568) | 4.48399087 |
32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.44137250 |
33 | doxorubicin metabolic process (GO:0044598) | 4.43902262 |
34 | daunorubicin metabolic process (GO:0044597) | 4.43902262 |
35 | polyketide metabolic process (GO:0030638) | 4.43902262 |
36 | response to gravity (GO:0009629) | 4.42656044 |
37 | response to pheromone (GO:0019236) | 4.39050203 |
38 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.38842873 |
39 | linoleic acid metabolic process (GO:0043651) | 4.36944304 |
40 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.33312464 |
41 | L-phenylalanine catabolic process (GO:0006559) | 4.29690324 |
42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.29690324 |
43 | homocysteine metabolic process (GO:0050667) | 4.26055438 |
44 | positive regulation of interleukin-4 production (GO:0032753) | 4.24922487 |
45 | T cell migration (GO:0072678) | 4.20550168 |
46 | tolerance induction (GO:0002507) | 4.20283522 |
47 | T cell selection (GO:0045058) | 4.12594950 |
48 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.12124756 |
49 | L-phenylalanine metabolic process (GO:0006558) | 4.12124756 |
50 | primary alcohol catabolic process (GO:0034310) | 4.09371374 |
51 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.09280126 |
52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.97958189 |
53 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.95386733 |
54 | NIK/NF-kappaB signaling (GO:0038061) | 3.88757633 |
55 | endothelial cell chemotaxis (GO:0035767) | 3.87352603 |
56 | amine catabolic process (GO:0009310) | 3.86760538 |
57 | cellular biogenic amine catabolic process (GO:0042402) | 3.86760538 |
58 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.83200148 |
59 | amyloid precursor protein metabolic process (GO:0042982) | 3.79630064 |
60 | valine metabolic process (GO:0006573) | 3.74463214 |
61 | regulation of natural killer cell differentiation (GO:0032823) | 3.72926170 |
62 | cellular glucuronidation (GO:0052695) | 3.71176250 |
63 | serine family amino acid catabolic process (GO:0009071) | 3.70941688 |
64 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.69734655 |
65 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.68954267 |
66 | positive T cell selection (GO:0043368) | 3.67756642 |
67 | bile acid biosynthetic process (GO:0006699) | 3.65749165 |
68 | plasma lipoprotein particle organization (GO:0071827) | 3.65041430 |
69 | cellular response to interleukin-15 (GO:0071350) | 3.64982713 |
70 | regulation of interleukin-13 production (GO:0032656) | 3.63242019 |
71 | regulation of interleukin-4 production (GO:0032673) | 3.62818009 |
72 | cholesterol efflux (GO:0033344) | 3.55846840 |
73 | multicellular organismal water homeostasis (GO:0050891) | 3.55083859 |
74 | urea metabolic process (GO:0019627) | 3.49227753 |
75 | urea cycle (GO:0000050) | 3.49227753 |
76 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 3.48266666 |
77 | protein carboxylation (GO:0018214) | 3.47575639 |
78 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.47575639 |
79 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.44774484 |
80 | lipoxygenase pathway (GO:0019372) | 3.40541390 |
81 | regulation of defense response to virus by virus (GO:0050690) | 3.40474942 |
82 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.40343445 |
83 | leukocyte aggregation (GO:0070486) | 3.38699345 |
84 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.38392528 |
85 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.33533117 |
86 | purine ribonucleotide transport (GO:0015868) | 3.33431630 |
87 | amyloid precursor protein catabolic process (GO:0042987) | 3.33423743 |
88 | aromatic amino acid family metabolic process (GO:0009072) | 3.33031538 |
89 | alpha-amino acid catabolic process (GO:1901606) | 3.30375236 |
90 | glucuronate metabolic process (GO:0019585) | 3.26782500 |
91 | uronic acid metabolic process (GO:0006063) | 3.26782500 |
92 | ethanol metabolic process (GO:0006067) | 3.26764264 |
93 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.26510396 |
94 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.25242632 |
95 | short-chain fatty acid metabolic process (GO:0046459) | 3.25179228 |
96 | purine nucleotide transport (GO:0015865) | 3.25132153 |
97 | protein-lipid complex subunit organization (GO:0071825) | 3.22915434 |
98 | alpha-linolenic acid metabolic process (GO:0036109) | 3.20222534 |
99 | sulfur amino acid catabolic process (GO:0000098) | 3.19120573 |
100 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.18566422 |
101 | regulation of cholesterol metabolic process (GO:0090181) | 3.18489964 |
102 | NAD biosynthetic process (GO:0009435) | 3.18435463 |
103 | regulation of triglyceride catabolic process (GO:0010896) | 3.17981264 |
104 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.16600398 |
105 | indolalkylamine metabolic process (GO:0006586) | 3.16376856 |
106 | glutamate metabolic process (GO:0006536) | 3.14960767 |
107 | cellular modified amino acid catabolic process (GO:0042219) | 3.14180019 |
108 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.13525282 |
109 | negative regulation of sterol transport (GO:0032372) | 3.11680961 |
110 | negative regulation of cholesterol transport (GO:0032375) | 3.11680961 |
111 | cysteine metabolic process (GO:0006534) | 3.11460441 |
112 | negative regulation of stress fiber assembly (GO:0051497) | 3.11165999 |
113 | ear development (GO:0043583) | 3.10424167 |
114 | response to interleukin-15 (GO:0070672) | 3.08890464 |
115 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.07892074 |
116 | desmosome organization (GO:0002934) | 3.06389552 |
117 | nitrogen cycle metabolic process (GO:0071941) | 3.05442144 |
118 | regulation of gamma-delta T cell activation (GO:0046643) | 3.05425543 |
119 | adenine nucleotide transport (GO:0051503) | 3.04982650 |
120 | cellular ketone body metabolic process (GO:0046950) | 3.04122086 |
121 | activation of MAPKKK activity (GO:0000185) | 3.03780266 |
122 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.02167371 |
123 | acylglycerol homeostasis (GO:0055090) | 3.01552943 |
124 | triglyceride homeostasis (GO:0070328) | 3.01552943 |
125 | cellular amino acid catabolic process (GO:0009063) | 3.00830133 |
126 | cellular response to interleukin-4 (GO:0071353) | 2.98063236 |
127 | tRNA methylation (GO:0030488) | 2.97136867 |
128 | embryonic process involved in female pregnancy (GO:0060136) | 2.97078499 |
129 | water homeostasis (GO:0030104) | 2.96725323 |
130 | regulation of protein activation cascade (GO:2000257) | 2.96621638 |
131 | COPI coating of Golgi vesicle (GO:0048205) | 2.96430553 |
132 | Golgi transport vesicle coating (GO:0048200) | 2.96430553 |
133 | glyoxylate metabolic process (GO:0046487) | 2.95249735 |
134 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.95002215 |
135 | tyrosine metabolic process (GO:0006570) | 2.94041643 |
136 | coenzyme catabolic process (GO:0009109) | 2.92851073 |
137 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.92265684 |
138 | negative regulation of lipase activity (GO:0060192) | 2.91026266 |
139 | lymphocyte migration (GO:0072676) | 2.90893343 |
140 | plasma lipoprotein particle assembly (GO:0034377) | 2.90142593 |
141 | negative regulation of cell killing (GO:0031342) | 2.87948359 |
142 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87948359 |
143 | regulation of histone H3-K27 methylation (GO:0061085) | 2.87518659 |
144 | GDP-mannose metabolic process (GO:0019673) | 2.87031590 |
145 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.86365792 |
146 | regulation of sequestering of triglyceride (GO:0010889) | 2.85150633 |
147 | negative regulation of astrocyte differentiation (GO:0048712) | 2.83755941 |
148 | negative regulation of granulocyte differentiation (GO:0030853) | 2.83369583 |
149 | bile acid metabolic process (GO:0008206) | 2.83307544 |
150 | rRNA transcription (GO:0009303) | 2.81522185 |
151 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.78314825 |
152 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.78273800 |
153 | apoptotic process involved in morphogenesis (GO:0060561) | 2.77608845 |
154 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.77554572 |
155 | positive regulation of protein sumoylation (GO:0033235) | 2.77317683 |
156 | positive regulation of cholesterol transport (GO:0032376) | 2.76958282 |
157 | positive regulation of sterol transport (GO:0032373) | 2.76958282 |
158 | positive regulation of extracellular matrix organization (GO:1903055) | 2.76781300 |
159 | regulation of complement activation (GO:0030449) | 2.76512457 |
160 | response to type I interferon (GO:0034340) | 2.75665633 |
161 | signal complex assembly (GO:0007172) | 2.75124886 |
162 | positive regulation of steroid metabolic process (GO:0045940) | 2.74886117 |
163 | ketone body metabolic process (GO:1902224) | 2.74355431 |
164 | cellular response to type I interferon (GO:0071357) | 2.74041856 |
165 | type I interferon signaling pathway (GO:0060337) | 2.74041856 |
166 | positive regulation of DNA recombination (GO:0045911) | 2.74041283 |
167 | anion homeostasis (GO:0055081) | 2.73999937 |
168 | positive regulation of histone deacetylation (GO:0031065) | 2.73750138 |
169 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.73683594 |
170 | sterol catabolic process (GO:0016127) | 2.73130910 |
171 | cholesterol catabolic process (GO:0006707) | 2.73130910 |
172 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.70658397 |
173 | regulation of interleukin-5 production (GO:0032674) | 2.70174830 |
174 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.69758289 |
175 | regulation of extracellular matrix organization (GO:1903053) | 2.69649831 |
176 | regulation of meiosis I (GO:0060631) | 2.69633484 |
177 | regulation of T cell tolerance induction (GO:0002664) | 2.67122282 |
178 | hepatocyte apoptotic process (GO:0097284) | 2.62057654 |
179 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.61905375 |
180 | activation of Rac GTPase activity (GO:0032863) | 2.61246135 |
181 | negative regulation of response to biotic stimulus (GO:0002832) | 2.61108933 |
182 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.60989723 |
183 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.59989008 |
184 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.58596335 |
185 | regulation of translational fidelity (GO:0006450) | 2.57963811 |
186 | regulation of nuclease activity (GO:0032069) | 2.57416919 |
187 | positive regulation of nuclease activity (GO:0032075) | 2.56570153 |
188 | positive regulation of interleukin-2 production (GO:0032743) | 2.56131177 |
189 | negative regulation of interleukin-2 production (GO:0032703) | 2.54331570 |
190 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.53596797 |
191 | histone H3-K4 methylation (GO:0051568) | 2.50816972 |
192 | cellular response to virus (GO:0098586) | 2.50495393 |
193 | mannose metabolic process (GO:0006013) | 2.49361470 |
194 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.46957080 |
195 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.45478885 |
196 | prostaglandin biosynthetic process (GO:0001516) | 2.44717987 |
197 | prostanoid biosynthetic process (GO:0046457) | 2.44717987 |
198 | response to interleukin-4 (GO:0070670) | 2.42382941 |
199 | positive regulation of epidermis development (GO:0045684) | 2.42354111 |
200 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.40881532 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.03860042 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.79490546 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.53395740 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.47265189 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.31434153 |
6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.08268727 |
7 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.97520557 |
8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.90160416 |
9 | MYC_22102868_ChIP-Seq_BL_Human | 2.85933368 |
10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.82322013 |
11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.81981465 |
12 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.72355041 |
13 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.45443172 |
14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39887197 |
15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.32692929 |
16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.32385839 |
17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.31084718 |
18 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.30599078 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.19534797 |
20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.19531391 |
21 | * MAF_26560356_Chip-Seq_TH1_Human | 2.12691623 |
22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.12604284 |
23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.09228585 |
24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.06864670 |
25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.05318620 |
26 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.00459874 |
27 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.00128858 |
28 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.96683232 |
29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93704707 |
30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.90228368 |
31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.89057671 |
32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.88980771 |
33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88259731 |
34 | MAF_26560356_Chip-Seq_TH2_Human | 1.86497604 |
35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.84291998 |
36 | RXR_22108803_ChIP-Seq_LS180_Human | 1.73245784 |
37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71347357 |
38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.66914499 |
39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64481637 |
40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59554151 |
41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.58878237 |
42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58271956 |
43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57451531 |
44 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.56515722 |
45 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.54126267 |
46 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.53140632 |
47 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53140632 |
48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.51422094 |
49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.51174547 |
50 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.51061628 |
51 | ATF3_27146783_Chip-Seq_COLON_Human | 1.50908199 |
52 | MYB_26560356_Chip-Seq_TH1_Human | 1.50442290 |
53 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.50355958 |
54 | TP53_16413492_ChIP-PET_HCT116_Human | 1.49870864 |
55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.48976421 |
56 | P68_20966046_ChIP-Seq_HELA_Human | 1.48626978 |
57 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48509731 |
58 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.47529588 |
59 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46809044 |
60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46292778 |
61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46171133 |
62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45866997 |
63 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.45837792 |
64 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.42797417 |
65 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42413787 |
66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41684142 |
67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.40745870 |
68 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.39841831 |
69 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.39748762 |
70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39710253 |
71 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.39255324 |
72 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.38486486 |
73 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.37821423 |
74 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.36321431 |
75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.34995319 |
76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34792557 |
77 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34573613 |
78 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.34462526 |
79 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.34298682 |
80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.33472298 |
81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.32238639 |
82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31515237 |
83 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30745843 |
84 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.30289443 |
85 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.29257411 |
86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28590292 |
87 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28201019 |
88 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27160032 |
89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26707635 |
90 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26649201 |
91 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.26587193 |
92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25868208 |
93 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.25757278 |
94 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25346439 |
95 | * MYB_26560356_Chip-Seq_TH2_Human | 1.24923083 |
96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24913281 |
97 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24750237 |
98 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.24382289 |
99 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.24100748 |
100 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.23524361 |
101 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.23494965 |
102 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23036578 |
103 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.22750176 |
104 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.22750176 |
105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22739937 |
106 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22666302 |
107 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.22356822 |
108 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22064784 |
109 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22062430 |
110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20095571 |
111 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19284135 |
112 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19198886 |
113 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19184787 |
114 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18800732 |
115 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17299555 |
116 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16978388 |
117 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16520386 |
118 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15438650 |
119 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15388355 |
120 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.15192493 |
121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14332871 |
122 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13864319 |
123 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.13453440 |
124 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13284553 |
125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12363954 |
126 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.12301869 |
127 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12159868 |
128 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11642595 |
129 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11316080 |
130 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11053212 |
131 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10662664 |
132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10421456 |
133 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10160059 |
134 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10019568 |
135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09937053 |
136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09937053 |
137 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09843688 |
138 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09664703 |
139 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09487342 |
140 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.09123503 |
141 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.09036765 |
142 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08365973 |
143 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08131177 |
144 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07982833 |
145 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07053241 |
146 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07048968 |
147 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.06900990 |
148 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06859070 |
149 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05943494 |
150 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05726583 |
151 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05719454 |
152 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05703613 |
153 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04650983 |
154 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04649432 |
155 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.04602631 |
156 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04523219 |
157 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04152764 |
158 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.03831308 |
159 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.03624008 |
160 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.03382817 |
161 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.02997779 |
162 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02927866 |
163 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02722823 |
164 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02559336 |
165 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.02145252 |
166 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01775531 |
167 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00985387 |
168 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98297388 |
169 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.98096024 |
170 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96835087 |
171 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96779009 |
172 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96461711 |
173 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.96351526 |
174 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96197721 |
175 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95749037 |
176 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95410180 |
177 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.95313504 |
178 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93150388 |
179 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93034654 |
180 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92916384 |
181 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90889348 |
182 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.90728857 |
183 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90655595 |
184 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.90142342 |
185 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.89974937 |
186 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89810260 |
187 | FUS_26573619_Chip-Seq_HEK293_Human | 0.89722622 |
188 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89592480 |
189 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89082686 |
190 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88823354 |
191 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88678954 |
192 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88549826 |
193 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88265620 |
194 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87875649 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 4.84573320 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.61897140 |
3 | MP0005365_abnormal_bile_salt | 4.33514979 |
4 | MP0005085_abnormal_gallbladder_physiolo | 4.30721331 |
5 | MP0002254_reproductive_system_inflammat | 3.94484142 |
6 | MP0003763_abnormal_thymus_physiology | 3.63818959 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.60200853 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.58973799 |
9 | MP0003191_abnormal_cellular_cholesterol | 3.40848155 |
10 | MP0010234_abnormal_vibrissa_follicle | 3.26570127 |
11 | MP0009840_abnormal_foam_cell | 3.13575434 |
12 | MP0004185_abnormal_adipocyte_glucose | 2.93381278 |
13 | MP0010329_abnormal_lipoprotein_level | 2.88312494 |
14 | MP0000685_abnormal_immune_system | 2.87648085 |
15 | MP0005671_abnormal_response_to | 2.86406876 |
16 | MP0002796_impaired_skin_barrier | 2.80647165 |
17 | MP0001873_stomach_inflammation | 2.74432695 |
18 | MP0004019_abnormal_vitamin_homeostasis | 2.70623720 |
19 | MP0005646_abnormal_pituitary_gland | 2.60422449 |
20 | MP0009333_abnormal_splenocyte_physiolog | 2.53739449 |
21 | MP0004381_abnormal_hair_follicle | 2.53122051 |
22 | MP0009697_abnormal_copulation | 2.50047799 |
23 | MP0005670_abnormal_white_adipose | 2.38879548 |
24 | MP0002098_abnormal_vibrissa_morphology | 2.29677878 |
25 | MP0005332_abnormal_amino_acid | 2.28687245 |
26 | MP0003453_abnormal_keratinocyte_physiol | 2.26775997 |
27 | MP0001348_abnormal_lacrimal_gland | 2.24934817 |
28 | MP0004947_skin_inflammation | 2.20944991 |
29 | MP0002166_altered_tumor_susceptibility | 2.20260465 |
30 | MP0005377_hearing/vestibular/ear_phenot | 2.20179972 |
31 | MP0003878_abnormal_ear_physiology | 2.20179972 |
32 | MP0003436_decreased_susceptibility_to | 2.06268472 |
33 | MP0001502_abnormal_circadian_rhythm | 2.04416093 |
34 | MP0001986_abnormal_taste_sensitivity | 2.01147256 |
35 | MP0005409_darkened_coat_color | 1.96912935 |
36 | MP0003252_abnormal_bile_duct | 1.96051643 |
37 | MP0002876_abnormal_thyroid_physiology | 1.92828492 |
38 | MP0005423_abnormal_somatic_nervous | 1.88895838 |
39 | MP0000703_abnormal_thymus_morphology | 1.84762803 |
40 | MP0003646_muscle_fatigue | 1.84112933 |
41 | MP0005000_abnormal_immune_tolerance | 1.83682496 |
42 | MP0001800_abnormal_humoral_immune | 1.79268805 |
43 | MP0005076_abnormal_cell_differentiation | 1.77340568 |
44 | MP0003300_gastrointestinal_ulcer | 1.74938623 |
45 | MP0003868_abnormal_feces_composition | 1.73215332 |
46 | MP0008995_early_reproductive_senescence | 1.72946490 |
47 | MP0005501_abnormal_skin_physiology | 1.71113993 |
48 | MP0005310_abnormal_salivary_gland | 1.69967327 |
49 | MP0002118_abnormal_lipid_homeostasis | 1.69403114 |
50 | MP0010155_abnormal_intestine_physiology | 1.68486638 |
51 | MP0000566_synostosis | 1.65810284 |
52 | MP0002420_abnormal_adaptive_immunity | 1.62909654 |
53 | MP0001819_abnormal_immune_cell | 1.62718358 |
54 | MP0005083_abnormal_biliary_tract | 1.61127715 |
55 | MP0004264_abnormal_extraembryonic_tissu | 1.60990146 |
56 | MP0002006_tumorigenesis | 1.60371007 |
57 | MP0002398_abnormal_bone_marrow | 1.59259484 |
58 | MP0002723_abnormal_immune_serum | 1.57459173 |
59 | MP0005025_abnormal_response_to | 1.57349324 |
60 | MP0003186_abnormal_redox_activity | 1.54713195 |
61 | MP0001835_abnormal_antigen_presentation | 1.53694513 |
62 | MP0000716_abnormal_immune_system | 1.52783614 |
63 | MP0002452_abnormal_antigen_presenting | 1.50337447 |
64 | MP0001346_abnormal_lacrimal_gland | 1.50211366 |
65 | MP0005058_abnormal_lysosome_morphology | 1.48192627 |
66 | MP0000678_abnormal_parathyroid_gland | 1.47011505 |
67 | MP0005666_abnormal_adipose_tissue | 1.46929042 |
68 | MP0002138_abnormal_hepatobiliary_system | 1.46388541 |
69 | MP0004742_abnormal_vestibular_system | 1.46037841 |
70 | MP0001666_abnormal_nutrient_absorption | 1.45798217 |
71 | MP0009785_altered_susceptibility_to | 1.44413613 |
72 | MP0002722_abnormal_immune_system | 1.41869124 |
73 | MP0001853_heart_inflammation | 1.40213320 |
74 | MP0000858_altered_metastatic_potential | 1.38374740 |
75 | MP0002736_abnormal_nociception_after | 1.35077082 |
76 | MP0000465_gastrointestinal_hemorrhage | 1.30682970 |
77 | MP0001216_abnormal_epidermal_layer | 1.30579251 |
78 | MP0009764_decreased_sensitivity_to | 1.29334093 |
79 | MP0005535_abnormal_body_temperature | 1.26643003 |
80 | MP0000689_abnormal_spleen_morphology | 1.23713198 |
81 | MP0002429_abnormal_blood_cell | 1.22945618 |
82 | MP0008961_abnormal_basal_metabolism | 1.22798071 |
83 | MP0003091_abnormal_cell_migration | 1.21900699 |
84 | MP0003866_abnormal_defecation | 1.21736589 |
85 | MP0005647_abnormal_sex_gland | 1.21273193 |
86 | MP0001270_distended_abdomen | 1.19756524 |
87 | MP0000609_abnormal_liver_physiology | 1.18620612 |
88 | MP0002249_abnormal_larynx_morphology | 1.18616900 |
89 | MP0004130_abnormal_muscle_cell | 1.18561679 |
90 | MP0003195_calcinosis | 1.18147393 |
91 | MP0003136_yellow_coat_color | 1.14658085 |
92 | MP0005023_abnormal_wound_healing | 1.13929043 |
93 | MP0002060_abnormal_skin_morphology | 1.13081675 |
94 | MP0008260_abnormal_autophagy | 1.12843027 |
95 | MP0000377_abnormal_hair_follicle | 1.09980076 |
96 | MP0004782_abnormal_surfactant_physiolog | 1.08306149 |
97 | MP0000627_abnormal_mammary_gland | 1.08243903 |
98 | MP0002282_abnormal_trachea_morphology | 1.07668150 |
99 | MP0004134_abnormal_chest_morphology | 1.05874821 |
100 | MP0000490_abnormal_crypts_of | 1.05012796 |
101 | MP0002163_abnormal_gland_morphology | 1.04304751 |
102 | MP0001845_abnormal_inflammatory_respons | 1.04041091 |
103 | MP0004510_myositis | 1.02338685 |
104 | MP0005451_abnormal_body_composition | 0.99492769 |
105 | MP0000604_amyloidosis | 0.99142065 |
106 | MP0000470_abnormal_stomach_morphology | 0.98393762 |
107 | MP0009931_abnormal_skin_appearance | 0.98363466 |
108 | MP0003690_abnormal_glial_cell | 0.98204643 |
109 | MP0000613_abnormal_salivary_gland | 0.97217791 |
110 | MP0003705_abnormal_hypodermis_morpholog | 0.95922787 |
111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93554034 |
112 | MP0001486_abnormal_startle_reflex | 0.92489638 |
113 | MP0001501_abnormal_sleep_pattern | 0.92216500 |
114 | MP0002089_abnormal_postnatal_growth/wei | 0.90949325 |
115 | MP0008004_abnormal_stomach_pH | 0.90502293 |
116 | MP0001790_abnormal_immune_system | 0.90229640 |
117 | MP0005387_immune_system_phenotype | 0.90229640 |
118 | MP0002877_abnormal_melanocyte_morpholog | 0.89291963 |
119 | MP0003950_abnormal_plasma_membrane | 0.89157698 |
120 | MP0009763_increased_sensitivity_to | 0.88807261 |
121 | MP0002933_joint_inflammation | 0.88709900 |
122 | MP0001968_abnormal_touch/_nociception | 0.88572027 |
123 | MP0002396_abnormal_hematopoietic_system | 0.88367538 |
124 | MP0001851_eye_inflammation | 0.88282164 |
125 | MP0001764_abnormal_homeostasis | 0.87380597 |
126 | MP0002019_abnormal_tumor_incidence | 0.87119718 |
127 | MP0010678_abnormal_skin_adnexa | 0.86390867 |
128 | MP0005375_adipose_tissue_phenotype | 0.86097002 |
129 | MP0005319_abnormal_enzyme/_coenzyme | 0.85838435 |
130 | MP0009250_abnormal_appendicular_skeleto | 0.85459222 |
131 | MP0010771_integument_phenotype | 0.84633739 |
132 | MP0002419_abnormal_innate_immunity | 0.83800109 |
133 | MP0009115_abnormal_fat_cell | 0.83395142 |
134 | MP0001661_extended_life_span | 0.83038403 |
135 | MP0002405_respiratory_system_inflammati | 0.81597522 |
136 | MP0006138_congestive_heart_failure | 0.81440481 |
137 | MP0002132_abnormal_respiratory_system | 0.81416285 |
138 | MP0001849_ear_inflammation | 0.81308644 |
139 | MP0001440_abnormal_grooming_behavior | 0.80907930 |
140 | MP0001340_abnormal_eyelid_morphology | 0.79753301 |
141 | MP0003959_abnormal_lean_body | 0.79426837 |
142 | MP0001881_abnormal_mammary_gland | 0.79023220 |
143 | MP0001727_abnormal_embryo_implantation | 0.78274699 |
144 | MP0004858_abnormal_nervous_system | 0.77275001 |
145 | MP0009765_abnormal_xenobiotic_induced | 0.77184501 |
146 | MP0005379_endocrine/exocrine_gland_phen | 0.75893910 |
147 | MP0000750_abnormal_muscle_regeneration | 0.74458723 |
148 | MP0000477_abnormal_intestine_morphology | 0.74355594 |
149 | MP0000383_abnormal_hair_follicle | 0.74177483 |
150 | MP0000367_abnormal_coat/_hair | 0.74167365 |
151 | MP0003566_abnormal_cell_adhesion | 0.73817635 |
152 | MP0002277_abnormal_respiratory_mucosa | 0.72985510 |
153 | MP0002971_abnormal_brown_adipose | 0.72221721 |
154 | MP0001963_abnormal_hearing_physiology | 0.71583384 |
155 | MP0005166_decreased_susceptibility_to | 0.70814555 |
156 | MP0002148_abnormal_hypersensitivity_rea | 0.70302898 |
157 | MP0006292_abnormal_olfactory_placode | 0.70242158 |
158 | MP0009780_abnormal_chondrocyte_physiolo | 0.70030455 |
159 | MP0005334_abnormal_fat_pad | 0.70004535 |
160 | MP0002822_catalepsy | 0.69905456 |
161 | MP0003656_abnormal_erythrocyte_physiolo | 0.69359440 |
162 | MP0000537_abnormal_urethra_morphology | 0.68172196 |
163 | MP0003448_altered_tumor_morphology | 0.68159350 |
164 | MP0005448_abnormal_energy_balance | 0.67851332 |
165 | MP0009745_abnormal_behavioral_response | 0.66405944 |
166 | MP0000163_abnormal_cartilage_morphology | 0.66254872 |
167 | MP0000462_abnormal_digestive_system | 0.66189361 |
168 | MP0003786_premature_aging | 0.65265825 |
169 | MP0005248_abnormal_Harderian_gland | 0.65054371 |
170 | MP0005621_abnormal_cell_physiology | 0.62995928 |
171 | MP0009643_abnormal_urine_homeostasis | 0.62314845 |
172 | MP0004885_abnormal_endolymph | 0.61324145 |
173 | MP0003638_abnormal_response/metabolism_ | 0.60634767 |
174 | MP0002115_abnormal_skeleton_extremities | 0.59253595 |
175 | MP0000598_abnormal_liver_morphology | 0.57731982 |
176 | MP0005220_abnormal_exocrine_pancreas | 0.57636448 |
177 | MP0004484_altered_response_of | 0.57493367 |
178 | MP0000026_abnormal_inner_ear | 0.56881890 |
179 | MP0008872_abnormal_physiological_respon | 0.55047933 |
180 | MP0003879_abnormal_hair_cell | 0.54359808 |
181 | MP0005503_abnormal_tendon_morphology | 0.53782203 |
182 | MP0005645_abnormal_hypothalamus_physiol | 0.53707586 |
183 | MP0001177_atelectasis | 0.53143309 |
184 | MP0004859_abnormal_synaptic_plasticity | 0.52887905 |
185 | MP0002078_abnormal_glucose_homeostasis | 0.52684919 |
186 | MP0003943_abnormal_hepatobiliary_system | 0.51987681 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Epiphyseal dysplasia (HP:0002656) | 5.42676815 |
2 | Increased IgE level (HP:0003212) | 5.23467894 |
3 | Intrahepatic cholestasis (HP:0001406) | 4.84813208 |
4 | Abnormal tarsal ossification (HP:0008369) | 4.49705011 |
5 | Vitreoretinal degeneration (HP:0000655) | 4.15915708 |
6 | Hyperlipoproteinemia (HP:0010980) | 4.10458737 |
7 | Irregular epiphyses (HP:0010582) | 3.81408466 |
8 | Hypoalphalipoproteinemia (HP:0003233) | 3.68222263 |
9 | Xanthomatosis (HP:0000991) | 3.64458955 |
10 | Deep venous thrombosis (HP:0002625) | 3.61380845 |
11 | Pili torti (HP:0003777) | 3.59046188 |
12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.55330255 |
13 | Neonatal short-limb short stature (HP:0008921) | 3.54970084 |
14 | Prolonged partial thromboplastin time (HP:0003645) | 3.50395213 |
15 | Broad face (HP:0000283) | 3.45296114 |
16 | Flat acetabular roof (HP:0003180) | 3.30391228 |
17 | Eczematoid dermatitis (HP:0000976) | 3.29058942 |
18 | Lip pit (HP:0100267) | 3.18789627 |
19 | Hypolipoproteinemia (HP:0010981) | 3.15727937 |
20 | Thoracic kyphosis (HP:0002942) | 3.15378968 |
21 | Recurrent bronchitis (HP:0002837) | 3.12715918 |
22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.09351761 |
23 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.09023248 |
24 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.08026400 |
25 | Gastrointestinal stroma tumor (HP:0100723) | 3.07642764 |
26 | Hyperacusis (HP:0010780) | 3.04875759 |
27 | Chronic hepatic failure (HP:0100626) | 3.04840861 |
28 | Chronic diarrhea (HP:0002028) | 3.03064467 |
29 | Cone-rod dystrophy (HP:0000548) | 2.97062473 |
30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.96694503 |
31 | Hypoglycemic seizures (HP:0002173) | 2.93710639 |
32 | Hypobetalipoproteinemia (HP:0003563) | 2.89666054 |
33 | Abnormality of the thoracic spine (HP:0100711) | 2.88979160 |
34 | Hyperglycinemia (HP:0002154) | 2.88910591 |
35 | IgA deficiency (HP:0002720) | 2.87735209 |
36 | J-shaped sella turcica (HP:0002680) | 2.78666175 |
37 | Hyperglycinuria (HP:0003108) | 2.77812492 |
38 | Verrucae (HP:0200043) | 2.76848237 |
39 | Papilloma (HP:0012740) | 2.76848237 |
40 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.72549188 |
41 | Genu varum (HP:0002970) | 2.72297001 |
42 | Small epiphyses (HP:0010585) | 2.71309175 |
43 | Increased intramyocellular lipid droplets (HP:0012240) | 2.69914936 |
44 | Hypoplastic ischia (HP:0003175) | 2.69620934 |
45 | Seborrheic dermatitis (HP:0001051) | 2.69186581 |
46 | IgM deficiency (HP:0002850) | 2.68941560 |
47 | Hydroxyprolinuria (HP:0003080) | 2.67367833 |
48 | Abnormality of proline metabolism (HP:0010907) | 2.67367833 |
49 | Lymphopenia (HP:0001888) | 2.66851568 |
50 | Ragged-red muscle fibers (HP:0003200) | 2.66844930 |
51 | Abnormal foot bone ossification (HP:0010675) | 2.65042402 |
52 | Hyperventilation (HP:0002883) | 2.64835982 |
53 | Abnormal hair laboratory examination (HP:0003328) | 2.64331425 |
54 | Loss of speech (HP:0002371) | 2.64171202 |
55 | Hypoglycemic coma (HP:0001325) | 2.62537083 |
56 | Bile duct proliferation (HP:0001408) | 2.62121293 |
57 | Abnormal biliary tract physiology (HP:0012439) | 2.62121293 |
58 | Macroorchidism (HP:0000053) | 2.62032037 |
59 | Neonatal hypoglycemia (HP:0001998) | 2.61924627 |
60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60416887 |
61 | Cupped ribs (HP:0000887) | 2.59764654 |
62 | Hypoplasia of the thymus (HP:0000778) | 2.59333934 |
63 | Abnormality of glycine metabolism (HP:0010895) | 2.54850407 |
64 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.54850407 |
65 | Bronchitis (HP:0012387) | 2.50904348 |
66 | Fat malabsorption (HP:0002630) | 2.49550965 |
67 | Increased muscle lipid content (HP:0009058) | 2.49212815 |
68 | Long palpebral fissure (HP:0000637) | 2.48252238 |
69 | Mesomelia (HP:0003027) | 2.48229348 |
70 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.47350532 |
71 | Micronodular cirrhosis (HP:0001413) | 2.45220261 |
72 | Enlarged kidneys (HP:0000105) | 2.44817585 |
73 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.44626156 |
74 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.43765843 |
75 | Trismus (HP:0000211) | 2.43600410 |
76 | Chronic sinusitis (HP:0011109) | 2.42920779 |
77 | Recurrent otitis media (HP:0000403) | 2.42117719 |
78 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.41702599 |
79 | Milia (HP:0001056) | 2.40230001 |
80 | Abnormality of the ischium (HP:0003174) | 2.40107946 |
81 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.38274516 |
82 | Abnormality of methionine metabolism (HP:0010901) | 2.35946317 |
83 | Abnormality of the common coagulation pathway (HP:0010990) | 2.35769604 |
84 | Abnormal gallbladder physiology (HP:0012438) | 2.35671434 |
85 | Cholecystitis (HP:0001082) | 2.35671434 |
86 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.33516680 |
87 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.30535407 |
88 | Abnormality of the salivary glands (HP:0010286) | 2.26926621 |
89 | Joint hemorrhage (HP:0005261) | 2.25168999 |
90 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.24961847 |
91 | Hyperparathyroidism (HP:0000843) | 2.24854100 |
92 | Vascular calcification (HP:0004934) | 2.24251451 |
93 | Complement deficiency (HP:0004431) | 2.23407611 |
94 | Ovoid vertebral bodies (HP:0003300) | 2.20053859 |
95 | Renal cortical cysts (HP:0000803) | 2.19856068 |
96 | Hyperammonemia (HP:0001987) | 2.18615270 |
97 | Epidermoid cyst (HP:0200040) | 2.17188080 |
98 | Steatorrhea (HP:0002570) | 2.16013051 |
99 | Beaking of vertebral bodies (HP:0004568) | 2.15476121 |
100 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.15232359 |
101 | Abnormality of T cells (HP:0002843) | 2.15174696 |
102 | Short femoral neck (HP:0100864) | 2.15171841 |
103 | Abnormality of the lumbar spine (HP:0100712) | 2.14513581 |
104 | Progressive sensorineural hearing impairment (HP:0000408) | 2.14082207 |
105 | IgG deficiency (HP:0004315) | 2.12026334 |
106 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10457649 |
107 | Hypercortisolism (HP:0001578) | 2.09794889 |
108 | Abnormality of carpal bone ossification (HP:0006257) | 2.09729140 |
109 | Growth hormone excess (HP:0000845) | 2.07974254 |
110 | Carpal bone hypoplasia (HP:0001498) | 2.04806699 |
111 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.04723415 |
112 | Recurrent sinusitis (HP:0011108) | 2.04421785 |
113 | Nail dystrophy (HP:0008404) | 2.04366103 |
114 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.03807396 |
115 | Emphysema (HP:0002097) | 2.03689365 |
116 | Abnormality of serum amino acid levels (HP:0003112) | 2.03329909 |
117 | Flattened epiphyses (HP:0003071) | 2.02210513 |
118 | Gastrointestinal inflammation (HP:0004386) | 2.01978897 |
119 | Symptomatic seizures (HP:0011145) | 2.01684510 |
120 | Metaphyseal dysplasia (HP:0100255) | 2.01621152 |
121 | Hypochromic microcytic anemia (HP:0004840) | 2.01462360 |
122 | Neuronal loss in central nervous system (HP:0002529) | 2.00262843 |
123 | Osteoarthritis (HP:0002758) | 2.00208572 |
124 | Abnormality of the axillary hair (HP:0100134) | 1.99729068 |
125 | Abnormality of secondary sexual hair (HP:0009888) | 1.99729068 |
126 | Basal cell carcinoma (HP:0002671) | 1.97498577 |
127 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97393479 |
128 | Plantar hyperkeratosis (HP:0007556) | 1.96732978 |
129 | Cervical subluxation (HP:0003308) | 1.96460742 |
130 | Paraparesis (HP:0002385) | 1.96370724 |
131 | Ridged nail (HP:0001807) | 1.96066963 |
132 | Cardiovascular calcification (HP:0011915) | 1.95970946 |
133 | Myokymia (HP:0002411) | 1.95960497 |
134 | Ketosis (HP:0001946) | 1.95236067 |
135 | Obstructive sleep apnea (HP:0002870) | 1.94974081 |
136 | Self-mutilation (HP:0000742) | 1.94901416 |
137 | Agammaglobulinemia (HP:0004432) | 1.93614754 |
138 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.93022710 |
139 | Absent epiphyses (HP:0010577) | 1.93022710 |
140 | Depressed nasal tip (HP:0000437) | 1.92956877 |
141 | Onycholysis (HP:0001806) | 1.92892439 |
142 | Thin ribs (HP:0000883) | 1.91381270 |
143 | Elevated alkaline phosphatase (HP:0003155) | 1.91204892 |
144 | Distal lower limb muscle weakness (HP:0009053) | 1.90974008 |
145 | Arthropathy (HP:0003040) | 1.90828583 |
146 | Panhypogammaglobulinemia (HP:0003139) | 1.88958681 |
147 | Respiratory distress (HP:0002098) | 1.88637443 |
148 | Abnormality of the femoral head (HP:0003368) | 1.88462494 |
149 | Abnormality of T cell physiology (HP:0011840) | 1.88342255 |
150 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.88275313 |
151 | Sex reversal (HP:0012245) | 1.87739393 |
152 | Abnormal sex determination (HP:0012244) | 1.87739393 |
153 | Hyperbilirubinemia (HP:0002904) | 1.87636596 |
154 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.86517659 |
155 | Abnormality of femoral epiphyses (HP:0006499) | 1.86517659 |
156 | Relative macrocephaly (HP:0004482) | 1.85829522 |
157 | Reduced antithrombin III activity (HP:0001976) | 1.85741579 |
158 | Slow saccadic eye movements (HP:0000514) | 1.85338187 |
159 | Conjugated hyperbilirubinemia (HP:0002908) | 1.85217037 |
160 | Recurrent fungal infections (HP:0002841) | 1.84672581 |
161 | Bronchomalacia (HP:0002780) | 1.84283520 |
162 | Mitral stenosis (HP:0001718) | 1.83714081 |
163 | Biconcave vertebral bodies (HP:0004586) | 1.83446292 |
164 | Ectopia lentis (HP:0001083) | 1.83000921 |
165 | Hepatoblastoma (HP:0002884) | 1.82868182 |
166 | Recurrent viral infections (HP:0004429) | 1.82684043 |
167 | Increased variability in muscle fiber diameter (HP:0003557) | 1.80876253 |
168 | Colitis (HP:0002583) | 1.80594275 |
169 | Abnormality of the gastric mucosa (HP:0004295) | 1.77733021 |
170 | Deformed sella turcica (HP:0002681) | 1.76722130 |
171 | Septate vagina (HP:0001153) | 1.76437920 |
172 | Insomnia (HP:0100785) | 1.75238836 |
173 | Multiple lipomas (HP:0001012) | 1.74838528 |
174 | Peripheral hypomyelination (HP:0007182) | 1.74799680 |
175 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.74743481 |
176 | Villous atrophy (HP:0011473) | 1.74743481 |
177 | Hypotrichosis (HP:0001006) | 1.74596498 |
178 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73729892 |
179 | Achilles tendon contracture (HP:0001771) | 1.72899640 |
180 | Retrobulbar optic neuritis (HP:0100654) | 1.72490785 |
181 | Optic neuritis (HP:0100653) | 1.72490785 |
182 | Progressive hearing impairment (HP:0001730) | 1.72390675 |
183 | Dysmetric saccades (HP:0000641) | 1.72380280 |
184 | Rough bone trabeculation (HP:0100670) | 1.72220645 |
185 | Increased cerebral lipofuscin (HP:0011813) | 1.71630685 |
186 | Abnormal blistering of the skin (HP:0008066) | 1.70602740 |
187 | Glossoptosis (HP:0000162) | 1.69857657 |
188 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.68406986 |
189 | Dysostosis multiplex (HP:0000943) | 1.66959202 |
190 | Pustule (HP:0200039) | 1.66950506 |
191 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.65912853 |
192 | Recurrent cutaneous fungal infections (HP:0011370) | 1.65912853 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 5.72984685 |
2 | SIK1 | 4.49109870 |
3 | SIK3 | 3.99373805 |
4 | SCYL2 | 3.70939363 |
5 | MAP4K1 | 3.70664184 |
6 | SMG1 | 3.55153800 |
7 | PRPF4B | 3.46945743 |
8 | EPHA2 | 3.09416401 |
9 | MUSK | 3.00869826 |
10 | CASK | 2.33710132 |
11 | MAPKAPK3 | 2.29826537 |
12 | SIK2 | 2.23302824 |
13 | TXK | 2.20036304 |
14 | TRPM7 | 2.19968716 |
15 | MAP3K14 | 2.18312099 |
16 | ERBB3 | 2.13168253 |
17 | NME2 | 2.01651612 |
18 | PKN2 | 1.98356607 |
19 | MARK3 | 1.88154133 |
20 | STK24 | 1.81595413 |
21 | ICK | 1.79029623 |
22 | EPHA4 | 1.77694073 |
23 | ERN1 | 1.65138577 |
24 | SGK2 | 1.64834996 |
25 | PINK1 | 1.57440299 |
26 | NME1 | 1.56473364 |
27 | MAP2K7 | 1.53691348 |
28 | TEC | 1.52593455 |
29 | SGK3 | 1.50571989 |
30 | MAP3K2 | 1.47375707 |
31 | TAOK2 | 1.45997479 |
32 | TNIK | 1.43831464 |
33 | MAPK13 | 1.43604002 |
34 | MST1R | 1.42429338 |
35 | LATS1 | 1.40359152 |
36 | BMX | 1.40184356 |
37 | BCKDK | 1.38419519 |
38 | NTRK3 | 1.36270988 |
39 | IKBKE | 1.34385227 |
40 | MST4 | 1.30569717 |
41 | CAMKK2 | 1.29083648 |
42 | MAPK11 | 1.28478147 |
43 | INSRR | 1.25407900 |
44 | PRKD3 | 1.22856407 |
45 | MAP2K3 | 1.22374843 |
46 | DAPK2 | 1.20016450 |
47 | SGK223 | 1.14807605 |
48 | SGK494 | 1.14807605 |
49 | HIPK2 | 1.14234260 |
50 | ADRBK2 | 1.13185562 |
51 | MAPK7 | 1.08191996 |
52 | MAP3K7 | 1.07280654 |
53 | PAK4 | 1.05261052 |
54 | EPHB1 | 1.04718499 |
55 | IRAK3 | 1.04534001 |
56 | CDK12 | 1.04077758 |
57 | CAMK1D | 1.02880052 |
58 | TESK1 | 1.01284251 |
59 | MAPK12 | 1.01015679 |
60 | CAMKK1 | 0.97406757 |
61 | BMPR2 | 0.97312205 |
62 | MAPK15 | 0.96990281 |
63 | IRAK4 | 0.96601200 |
64 | MAP3K4 | 0.96544169 |
65 | TYK2 | 0.95009718 |
66 | STK10 | 0.94778682 |
67 | DAPK1 | 0.94769940 |
68 | IRAK1 | 0.92540535 |
69 | DDR2 | 0.91714328 |
70 | MAP3K3 | 0.91091008 |
71 | STK38L | 0.89625874 |
72 | FGFR4 | 0.87615859 |
73 | PRKCE | 0.86760007 |
74 | PRKCG | 0.85990971 |
75 | CAMK4 | 0.82948594 |
76 | MAP2K4 | 0.82050642 |
77 | JAK1 | 0.81093533 |
78 | GRK1 | 0.80376364 |
79 | EEF2K | 0.78922060 |
80 | CAMK1G | 0.78291504 |
81 | VRK2 | 0.77391919 |
82 | MAPKAPK2 | 0.77140747 |
83 | CDK3 | 0.75941058 |
84 | MAP2K2 | 0.75406117 |
85 | TESK2 | 0.74466868 |
86 | CDC42BPA | 0.74416170 |
87 | LMTK2 | 0.73956283 |
88 | PDPK1 | 0.73486228 |
89 | PRKD2 | 0.73047295 |
90 | KDR | 0.73019990 |
91 | STK16 | 0.71944918 |
92 | JAK3 | 0.71712856 |
93 | MAP3K13 | 0.71146351 |
94 | TAOK1 | 0.71108499 |
95 | SRPK1 | 0.69985939 |
96 | ARAF | 0.69911926 |
97 | BTK | 0.69737505 |
98 | MAP3K11 | 0.69631480 |
99 | PAK3 | 0.68999899 |
100 | MTOR | 0.68681070 |
101 | MAP3K12 | 0.68104350 |
102 | TBK1 | 0.65803777 |
103 | STK3 | 0.65516210 |
104 | PRKCH | 0.65057154 |
105 | TYRO3 | 0.64998931 |
106 | TTN | 0.63629245 |
107 | RPS6KB1 | 0.63289655 |
108 | ZAP70 | 0.63243162 |
109 | ILK | 0.61793385 |
110 | MARK2 | 0.61534148 |
111 | BCR | 0.61001245 |
112 | PDK1 | 0.60893366 |
113 | YES1 | 0.59748626 |
114 | ITK | 0.59366758 |
115 | CAMK1 | 0.57908748 |
116 | GRK6 | 0.57158856 |
117 | PRKCI | 0.56446604 |
118 | EIF2AK2 | 0.55547496 |
119 | NUAK1 | 0.55477872 |
120 | PTK6 | 0.55140318 |
121 | MKNK2 | 0.55081319 |
122 | RIPK4 | 0.54621777 |
123 | RPS6KA4 | 0.53276958 |
124 | PRKAA1 | 0.52696463 |
125 | IKBKB | 0.52614899 |
126 | CHUK | 0.51318231 |
127 | MAP2K6 | 0.50067137 |
128 | FGFR3 | 0.49306889 |
129 | RPS6KB2 | 0.48765273 |
130 | IRAK2 | 0.48566243 |
131 | MAP3K9 | 0.48532899 |
132 | PRKCQ | 0.48492231 |
133 | DAPK3 | 0.48133889 |
134 | MAP3K10 | 0.47141409 |
135 | MAP3K6 | 0.46512754 |
136 | LRRK2 | 0.45494137 |
137 | CDK7 | 0.44080882 |
138 | RPS6KA2 | 0.43751237 |
139 | MAP3K1 | 0.43663163 |
140 | CSF1R | 0.43255810 |
141 | TRIB3 | 0.42255031 |
142 | MAPK4 | 0.41582484 |
143 | MAP3K8 | 0.41538537 |
144 | LCK | 0.40285722 |
145 | PRKCD | 0.40128510 |
146 | STK38 | 0.39670555 |
147 | CDK9 | 0.39178717 |
148 | CSK | 0.39037230 |
149 | PASK | 0.38355612 |
150 | PIM2 | 0.37991154 |
151 | EIF2AK3 | 0.37043825 |
152 | PRKAA2 | 0.36991134 |
153 | MAP3K5 | 0.36601554 |
154 | KSR1 | 0.35450583 |
155 | PRKG2 | 0.34909769 |
156 | CAMK2A | 0.34268986 |
157 | RPS6KC1 | 0.33384500 |
158 | RPS6KL1 | 0.33384500 |
159 | PRKACG | 0.33256253 |
160 | CSNK1G2 | 0.32778631 |
161 | ADRBK1 | 0.32125013 |
162 | PRKCA | 0.29540336 |
163 | IGF1R | 0.28899873 |
164 | SYK | 0.28872583 |
165 | PLK2 | 0.28777636 |
166 | PDK3 | 0.28695124 |
167 | PDK4 | 0.28695124 |
168 | PIM1 | 0.28213249 |
169 | PRKG1 | 0.27077860 |
170 | TNK2 | 0.24179804 |
171 | MAP2K1 | 0.24143275 |
172 | NLK | 0.23608262 |
173 | EPHA3 | 0.23489449 |
174 | MAPK3 | 0.22041886 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.24945744 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.73521946 |
3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.39524783 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.94712430 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.78981145 |
6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.68736908 |
7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.58232960 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.55746401 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55246584 |
10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39807458 |
11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.31890407 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.26867289 |
13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.13537076 |
14 | Peroxisome_Homo sapiens_hsa04146 | 2.10832328 |
15 | Allograft rejection_Homo sapiens_hsa05330 | 2.08384365 |
16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.05233398 |
17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02031482 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01400480 |
19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97968104 |
20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.94496720 |
21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.93029927 |
22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.91480866 |
23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.85410642 |
24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.82087647 |
25 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.75338577 |
26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.75106727 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73421464 |
28 | Prion diseases_Homo sapiens_hsa05020 | 1.72437607 |
29 | Measles_Homo sapiens_hsa05162 | 1.69784208 |
30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.65182833 |
31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.64100358 |
32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.63826769 |
33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.63365922 |
34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62589653 |
35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.60965247 |
36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60761247 |
37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.59670572 |
38 | Bile secretion_Homo sapiens_hsa04976 | 1.57200149 |
39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56800806 |
40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53809352 |
41 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.53422202 |
42 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.53063932 |
43 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.50181201 |
44 | Hepatitis C_Homo sapiens_hsa05160 | 1.48676276 |
45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47014474 |
46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45659396 |
47 | Apoptosis_Homo sapiens_hsa04210 | 1.42969519 |
48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42177634 |
49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.41528987 |
50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41378856 |
51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41317144 |
52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.40753226 |
53 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40697791 |
54 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39555694 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 1.37814495 |
56 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37173331 |
57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.37162836 |
58 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.33838614 |
59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32619105 |
60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.31052148 |
61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29675062 |
62 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27401305 |
63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.26583502 |
64 | Lysine degradation_Homo sapiens_hsa00310 | 1.26233564 |
65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25498307 |
66 | HTLV-I infection_Homo sapiens_hsa05166 | 1.23490446 |
67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21251384 |
68 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.16825470 |
69 | Influenza A_Homo sapiens_hsa05164 | 1.16493789 |
70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13998801 |
71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.13259997 |
72 | Spliceosome_Homo sapiens_hsa03040 | 1.10730732 |
73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06674842 |
74 | ABC transporters_Homo sapiens_hsa02010 | 1.05743998 |
75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03049816 |
76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02781915 |
77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02677815 |
78 | Circadian rhythm_Homo sapiens_hsa04710 | 1.02481406 |
79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.01693818 |
80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.01266086 |
81 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.01230620 |
82 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00983765 |
83 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00902160 |
84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99326948 |
85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99112068 |
86 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97849066 |
87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95430161 |
88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94338235 |
89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93113250 |
90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92195987 |
91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88733791 |
92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88479981 |
93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85966792 |
94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85561588 |
95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.85476415 |
96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84475652 |
97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84154089 |
98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84131034 |
99 | Prostate cancer_Homo sapiens_hsa05215 | 0.80586247 |
100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78206691 |
101 | Base excision repair_Homo sapiens_hsa03410 | 0.77989575 |
102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77427908 |
103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75115780 |
104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74147789 |
105 | Endocytosis_Homo sapiens_hsa04144 | 0.74112417 |
106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73577834 |
107 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.73530217 |
108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73383040 |
109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72340931 |
110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71900223 |
111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71337784 |
112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71134020 |
113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69411801 |
114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68792897 |
115 | Tuberculosis_Homo sapiens_hsa05152 | 0.67604735 |
116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66505142 |
117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65416660 |
118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65329355 |
119 | Shigellosis_Homo sapiens_hsa05131 | 0.65207440 |
120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64095016 |
121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63152800 |
122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63010181 |
123 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62329623 |
124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59485057 |
125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59332498 |
126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59207358 |
127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58678447 |
128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58410216 |
129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57785823 |
130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57547001 |
131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57454845 |
132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56680424 |
133 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56449388 |
134 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55942843 |
135 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55610929 |
136 | Alcoholism_Homo sapiens_hsa05034 | 0.55567374 |
137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54990570 |
138 | RNA transport_Homo sapiens_hsa03013 | 0.54923383 |
139 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54314844 |
140 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54148210 |
141 | Nicotine addiction_Homo sapiens_hsa05033 | 0.52614280 |
142 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51161841 |
143 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50727876 |
144 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50589840 |
145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48138511 |
146 | Taste transduction_Homo sapiens_hsa04742 | 0.47239509 |
147 | Morphine addiction_Homo sapiens_hsa05032 | 0.46336077 |
148 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.44721787 |
149 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43406273 |
150 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43040631 |
151 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41743640 |
152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41368196 |
153 | RNA polymerase_Homo sapiens_hsa03020 | 0.41254850 |
154 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40692295 |
155 | Bladder cancer_Homo sapiens_hsa05219 | 0.38976487 |
156 | Circadian entrainment_Homo sapiens_hsa04713 | 0.36760888 |
157 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34549916 |
158 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.33504325 |
159 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33192552 |
160 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32780872 |
161 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.32566887 |
162 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32037804 |
163 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30483099 |
164 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.29529406 |
165 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27318364 |
166 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.27154295 |
167 | Insulin secretion_Homo sapiens_hsa04911 | 0.27091285 |
168 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.26125665 |
169 | Insulin resistance_Homo sapiens_hsa04931 | 0.24702215 |
170 | Olfactory transduction_Homo sapiens_hsa04740 | 0.24679263 |
171 | Salivary secretion_Homo sapiens_hsa04970 | 0.23076069 |
172 | GABAergic synapse_Homo sapiens_hsa04727 | 0.20834767 |
173 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20577898 |
174 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20478095 |
175 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.18352964 |
176 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17835356 |
177 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.17807718 |
178 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.17520721 |
179 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16733848 |
180 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16367873 |
181 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.16325037 |
182 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16084426 |
183 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.15920238 |
184 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.15291473 |